(Q44314858)

1 December 2017

title

Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy (English)

1 reference

1 December 2017

main subject

acute coronary syndrome

1 reference

1

James L Januzzi

1 reference

1 December 2017

Marc S Sabatine

2

1 reference

1 December 2017

Ying Wan

3

1 reference

1 December 2017

Stephen J Servoss

4

1 reference

1 December 2017

Peter M DiBattiste

5

1 reference

1 December 2017

I k-Kyung Jang

6

1 reference

1 December 2017

Pierre Theroux

7

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

American Journal of Cardiology

1 December 2017

published in

1 reference

1 December 2017

volume

91

1 reference

1 December 2017

issue

4

1 reference

1 December 2017

page(s)

457-461

1 reference

Predictors of death during 5 years after hospital discharge among patients with a suspected acute coronary syndrome with particular emphasis on whether an infarction was developed.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Age and outcome after acute coronary syndromes without persistent ST-segment elevation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Ten year mortality in subsets of patients with an acute coronary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Drug treatment of elderly patients with acute myocardial infarction: practical recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Anti-thrombotic therapy for elderly patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Elderly Patients with Acute Coronary Syndromes: Higher Risk and Greater Benefit from Antithrombotic and Interventional Therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903247-2

10.1016/S0002-9149(02)03247-2

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference